Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its data-driven medicine

Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77 million Series E funding round, bringing its total raised to $140 million since the business was founded back in 2011. The company, which applies AI to DNA sequencing to enable what it dubs “data-driven medicine,” last…

Continue reading

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies

The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene editing technologies and (potentially) the whole field of microbiome-targeted therapies. Based in Research Triangle Park, N.C., Locus is commercializing research…

Continue reading